Our MR Linac Unit

The MR Linac machine combines two technologies – an MRI scanner and a linear accelerator – to precisely locate tumours, tailor the shape of X-ray beams in real time, and accurately deliver doses of radiation even to moving tumours.

Located at the Sutton site of the ICR and The Royal Marsden NHS Foundation Trust, the MR Linac Unit is the first of its kind in the UK and only the fourth in the world. This page collects together recent news regarding this groundbreaking technology which will be used to precisely locate tumours and accurately deliver doses of radiation.

 

01/08/18

An MRI scanner

Image: An MRI scanner

Physicists from The Institute of Cancer Research, London, and our partner hospital, The Royal Marsden NHS Foundation Trust, combined standard 2D magnetic resonance imaging (MRI) images of the chests of healthy volunteers to create 'super-resolution' videos, showing the lungs expanding and contracting.

The technique creates images of structures inside the body that are five times more detailed than other methods using MRI, and can also be carried out more quickly.

The new study, published in the journal Radiotherapy and Oncology, could help to deliver more precise radiotherapy for diseases like lung cancer by helping doctors to predict the location of a tumour more effectively, even as it moves.

It also shows the potential of a specific type of MRI called T2-weighted MRI in dual imaging and radiotherapy systems that aim to image and treat tumours simultaneously – like the MR-Linac, which is being developed by researchers including physicists at the ICR and The Royal Marsden.

The ICR's MR Linac machine combines two technologies to tailor the shape of X-ray beams in real time and accurately deliver doses of radiation.

Find out more

Super-resolution MRI

Animation: 3D super-resolution MRI scans

More accurate radiotherapy

In the study, which was largely funded by Cancer Research UK, eight healthy volunteers were scanned using standard MRI.

Images were sorted and stitched together by computer to build accurate, high resolution movies of them breathing in and out.

The technique developed by ICR researchers also reproduces detailed images of 'slices' of the body, at any position or time, by combining multiple MRIs of the body from different orientations.

The high definition images also have fewer 'artefacts' than standard MRI images – visible glitches caused by missing data that can obscure important structures in the body, compared with other similar techniques.

The technique could help to plan more accurate radiotherapy that could be adapted throughout the course of treatment as tumours shrink.

“New technique”

Team leader Professor Martin Leach said: “Radiotherapy treatment for lung cancer is currently planned using CT scans of patients to measure their breathing patterns, but it's hard to see the tumour on these images and so the radiotherapy delivered may not be effectively treating the cancer.”

Lead author Dr Andreas Wetscherek (from the Radiotherapy Physics Modelling Team), said: “Our study describes the development of a new technique for rebuilding static MRI images into moving videos, which could give MRI the edge over CT scans in the future planning of radiotherapy treatment.

“It also shows the potential of moving T2 weighted MRI for systems like the MR Linac, which are being designed to image and treat patients with radiotherapy at the same time.”

If you’re a journalist and want to find out more, you can contact our media relations team.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With Gift Aid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With Gift Aid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.